Page 3

eMag_264548_NCS Currents_December2016_3

NCS Leadership Since my hula dance demonstration at the business meeting in Washington 2016-2017 DC, the executive committee, NCS staff, and I have been hitting the ground running. It is amazing to see how much the Society has grown over the years and how involved the members are in this growth. Officers Michel Torbey, MD, President Gretchen Brophy, PharmD, Vice President Jose Suarez, MD, Treasurer Mary Kay Bader, MSN, CNS, Secretary Ed Manno, MD, Immediate Past President Board of Directors Neeraj Badjatia, MD Jordan Bonomo, MD Julian Bösel, MD Marion Buckwalter, MD, PhD Guadalupe Castillo-Abrego, MD Sherry Chou, MD W. David Freeman, MD Jennifer Frontera, MD David Greer, MD Theresa Human, PharmD John Lewin, PharmD Chad Miller, MD Susanne Muehlschlegel, MD Paul Nyquist, MD Kristine O’Phelan, MD Fred Rincon, MD David Seder, MD Kevin Sheth, MD Lori Shutter, MD Panos Varelas, MD, PhD Susan Yeager, NP, RN Executive Director JoAnn Taie Editor-in-Chief, Neurocritical Care Eelco Wijdicks, MD, PhD Neurocritical Care Society 5841 Cedar Lake Road, Suite 204 Minneapolis, MN 55416 Phone: (952) 646-2031 Fax: (952) 545-6073 Website: www.neurocriticalcare.org Email: info@neurocriticalcare.org It is important for us as a society to make sure we serve all our members, especially being the only multidisciplinary Neurocritical care society in the world. The Executive Committee recently approved a proposal to develop a committee for Advanced Practice Providers. This proposal provided recommendations on activities that would support this segment of our members. Jessica White and Sarah Livesay have agreed to serve as Co-Chairs with Susan Yeager serving as the BOD Liaison.  Other members of the committee will be identified through a call for volunteers to the membership, so stay tuned and get involved!! There has been a lot of discussions within the NCS community about how can the Society integrate quality metrics in the Neurocritical care unit. The Executive Committee recently approved two initiatives supporting this strategic goal. The first is regarding the development of a quality metrics white paper that outlines what constitutes a quality neuro-ICU.  The Advocacy Committee will spearhead this initiative.  The second initiative is for the Guidelines Committee to develop guidelines around quality measures which identify high level of practices based on proven criteria.  The difference between the two quality-based initiatives is that the white paper would address the physical environment while the guidelines would identify core practices that are evidence-based.  Both groups will collaborate to ensure their work compliments and supports the other.  The goal is to have these developed by the 2017 meeting so that a joint program can be presented.     Last year, Dr. Edward Manno created several task forces. Membership on these task forces required special expertise in five key areas including branding, certification, global, ENLS and funding.  The recommendations generated from the task forces were instrumental in guiding the Board in developing the NCS’s strategic direction over the next three years. I am happy to announce that the work of the task forces is now complete and I’d like to thank the task force chairs and members for their involvement as we look forward to an active year implementing our strategic initiatives.  I would like to remind our junior members that applications for the 2017 NCS Research Fellowship are now being accepted. This program is aimed at promising applicants who are seeking a career in clinical or translational research in Neurocritical care and ultimately wish to become independent investigators. The program continues to receive high quality applications. Hopefully in the next year we will be able to increase the number of fellowships offered. As we are approaching the Holidays Season, I would personally like to express my best wishes for each and every member of the Society. As a member, you are an integral part of NCS. Contributions have allowed NCS to expand its membership, increase its educational offerings, and contribute more than $25,000 to research this year alone, ultimately helping NCS members to better provide and advocate for the highest quality of care for patients with critical neurological illnesses throughout the world. Hopefully more to come!! Michel Torbey, MD, MPH, FCCM, FAHA President, Neurocritical Care Society PRESIDENT’S COLUMN The First 70 days!! 3


eMag_264548_NCS Currents_December2016_3
To see the actual publication please follow the link above